GE HealthCare and Medis team up for non-invasive coronary… | Medexec
Request Services

The global market for robotic surgical systems will reach $10B by the end of 2024 and $15.8B by 2030

GE HealthCare, a leader in medical technology, and Medis, a specialist in medical imaging software, have announced a partnership to improve non-invasive coronary assessments. This collaboration represents a major advancement in cardiovascular diagnostics, showcasing the potential of integrating imaging technologies with advanced software solutions.

The advanced imaging systems from GE HealthCare, along with Medis’s pioneering software, offer thorough and precise evaluations of coronary arteries, empowering physicians to make well-informed decisions about patient care. The collaboration aims to elevate the diagnostic process, minimise the necessity for invasive procedures and ultimately enhance patient outcomes.

GlobalData projects that the global market for robotic surgical systems and their accessories will reach $10 billion by the end of 2024, and expects the market to surge to $15.8 billion by 2030. Several factors are anticipated to drive this expansion: increasing demand from the growing elderly population seeking precise and minimally invasive surgical solutions, a focus on value-based healthcare to enhance surgical outcomes, and ongoing technological advancements that will lead to the development of more efficient and less invasive robotic surgical platforms.

Several factors are fueling the growth of non-invasive coronary assessments: the rising incidence of cardiovascular diseases, the heightened focus on early diagnosis and preventive care and ongoing advancements in imaging technologies. These aspects are essential for enhancing patient outcomes and alleviating the overall strain on healthcare systems.

The partnership exemplifies the transformative potential inherent in the integration of imaging and software technologies within cardiovascular diagnostics, emphasising a dedication to patient-centered innovation. As the collaboration progresses, GE HealthCare and Medis are positioned to deliver progressive solutions that elevate diagnostic accuracy and enhance patient care on a global scale.

This article was originally published by and can be viewed here